Cargando…
Liver ChIP-seq analysis in FGF19-treated mice reveals SHP as a global transcriptional partner of SREBP-2
BACKGROUND: Fibroblast growth factor-19 (FGF19) is an intestinal hormone that mediates postprandial metabolic responses in the liver. The unusual orphan nuclear receptor, small heterodimer partner (SHP), acts as a co-repressor for many transcriptional factors and has been implicated in diverse biolo...
Autores principales: | Kim, Young-Chae, Byun, Sangwon, Zhang, Yang, Seok, Sunmi, Kemper, Byron, Ma, Jian, Kemper, Jongsook Kim |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4669652/ https://www.ncbi.nlm.nih.gov/pubmed/26634251 http://dx.doi.org/10.1186/s13059-015-0835-6 |
Ejemplares similares
-
Feeding activates FGF15‐SHP‐TFEB‐mediated lipophagy in the gut
por: Seok, Sunmi, et al.
Publicado: (2022) -
AhR and SHP regulate phosphatidylcholine and S-adenosylmethionine levels in the one-carbon cycle
por: Kim, Young-Chae, et al.
Publicado: (2018) -
Intestinal FGF15/19 physiologically repress hepatic lipogenesis in the late fed-state by activating SHP and DNMT3A
por: Kim, Young-Chae, et al.
Publicado: (2020) -
Transgenic mice lacking FGF15/19-SHP phosphorylation display altered bile acids and gut bacteria, promoting nonalcoholic fatty liver disease
por: Kim, Young-Chae, et al.
Publicado: (2023) -
Fasting-induced FGF21 signaling activates hepatic autophagy and lipid degradation via JMJD3 histone demethylase
por: Byun, Sangwon, et al.
Publicado: (2020)